Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
tranexamic acid, Quantity: 500 mg
Southern Cross Pharma Pty Ltd
Tranexamic acid
Tablet, film coated
Excipient Ingredients: croscarmellose sodium; purified talc; titanium dioxide; microcrystalline cellulose; vanillin; macrogol 8000; colloidal anhydrous silica; povidone; magnesium stearate; basic butylated methacrylate copolymer
Oral
100 tablets
(S4) Prescription Only Medicine
Oral Administration Hereditary angioneurotic oedema. Short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. Menorrhagia.
Visual Identification: White to slightly yellowish, film coated, capsule shaped, biconvex, 18 mm x 8 mm, with a break-line and embossed "TXA 500"; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2017-01-30